Cellectar BioSciences Inc. buy Oppenheimer Holdings Inc.
Start price
28.03.24
/
50%
€3.72
Target price
28.03.25
€11.09
Performance (%)
-19.89%
Price
08.05.24
€2.98
Summary
This prediction is currently active. The prediction for Cellectar BioSciences Inc. disappoints with a performance of -19.89%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cellectar BioSciences Inc. | 2.759% | 2.759% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Cellectar BioSciences Inc. diskutieren
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $12.00 price target on the stock, up previously from $11.00.
Ratings data for CLRB provided by MarketBeat